Charles Kouanfack

4.0k total citations
119 papers, 2.0k citations indexed

About

Charles Kouanfack is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Charles Kouanfack has authored 119 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Infectious Diseases, 51 papers in Epidemiology and 38 papers in Virology. Recurrent topics in Charles Kouanfack's work include HIV/AIDS Research and Interventions (60 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (38 papers). Charles Kouanfack is often cited by papers focused on HIV/AIDS Research and Interventions (60 papers), HIV/AIDS drug development and treatment (40 papers) and HIV Research and Treatment (38 papers). Charles Kouanfack collaborates with scholars based in Cameroon, France and United States. Charles Kouanfack's co-authors include Éric Delaporte, Sinata Koulla‐Shiro, Christian Laurent, Eitel Mpoudi‐Ngolé, Avelin F. Aghokeng, Anke Bourgeois, Martine Peeters, Pierre Ongolo‐Zogo, Alexandra Calmy and Jean Jacques Noubiap and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Charles Kouanfack

107 papers receiving 1.9k citations

Peers

Charles Kouanfack
Carole L. Wallis South Africa
Marta Ackers United States
Raph L Hamers Netherlands
Martina Penazzato Switzerland
Zara Shubber United Kingdom
Charles B. Holmes United States
Amitabh B. Suthar United States
Charles Kouanfack
Citations per year, relative to Charles Kouanfack Charles Kouanfack (= 1×) peers Sikhulile Moyo

Countries citing papers authored by Charles Kouanfack

Since Specialization
Citations

This map shows the geographic impact of Charles Kouanfack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Kouanfack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Kouanfack more than expected).

Fields of papers citing papers by Charles Kouanfack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Kouanfack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Kouanfack. The network helps show where Charles Kouanfack may publish in the future.

Co-authorship network of co-authors of Charles Kouanfack

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Kouanfack. A scholar is included among the top collaborators of Charles Kouanfack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Kouanfack. Charles Kouanfack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picchio, Camila A, Claude Tayou Tagny, Emmanuel Seremba, et al.. (2024). Acceptability and Feasibility of the Plasma Separation Card for an Integrated Model of Care for HBV and HCV Screening Among People Attending HIV Clinics in Cameroon and Uganda. Journal of Epidemiology and Global Health. 14(3). 827–838. 2 indexed citations
2.
Nelson, LaRon E., et al.. (2024). The Feasibility and Acceptability of Using Mobile Applications for HIV Testing, Prevention, and Treatment Among Adolescent Girls and Young Women in Cameroon: A Cross-Sectional Study. Journal of the Association of Nurses in AIDS Care. 35(3). 210–221. 2 indexed citations
3.
Hill, Andrew, Simiso Sokhela, Bryony Simmons, et al.. (2024). Low CD4 counts predict excessive weight gains during first-line treatment for HIV. Journal of Antimicrobial Chemotherapy. 79(9). 2369–2378. 4 indexed citations
6.
Sephton-Clark, Poppy, Elvis Temfack, Jennifer L. Tenor, et al.. (2023). Genetic diversity and microevolution in clinical Cryptococcus isolates from Cameroon. Medical Mycology. 61(12). 1 indexed citations
7.
Ayouba, Ahidjo, Cécé Kpamou, Guillaume Thaurignac, et al.. (2023). Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies. Open Forum Infectious Diseases. 10(5). ofad216–ofad216. 3 indexed citations
8.
Kouanfack, Charles, et al.. (2023). Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde. Virology Journal. 20(1). 165–165. 2 indexed citations
9.
Kouanfack, Charles, et al.. (2021). Clinical, Biochemical and CT-Scan Characteristics of Obesity Onset in Patients Under Dolutegravir in Comparison With Low-Dose-Efavirenz: A Pilot Study in Cameroon. Health sciences and disease. 22(3). 2 indexed citations
10.
Kouanfack, Charles, et al.. (2021). Use of Trained Non-Medical Staff to Improve Access to HIV Testing Services in Africa: Implementation of the World Health Organization Opt-out Approach in Cameroon. SHILAP Revista de lepidopterología. 10(1). 119–127. 2 indexed citations
11.
Kouanfack, Charles, et al.. (2020). Retention in HIV/AIDS Management Services: is it Really Poor? The Case of Yaounde Central Hospital in Cameroon. SHILAP Revista de lepidopterología. 9(2). 207–212.
12.
Kouanfack, Charles, et al.. (2019). Epidemiology of Opportunistic Infections in HIV Infected Patients on Treatment in Accredited HIV Treatment Centers in Cameroon. SHILAP Revista de lepidopterología. 8(2). 163–172. 6 indexed citations
13.
Kouanfack, Charles, et al.. (2019). Non-Occupational HIV Post-exposure Prophylaxis: A 10-Year Retrospective Review of Data Following Sexual Exposure From Yaounde Central Hospital, Cameroon. SHILAP Revista de lepidopterología. 8(2). 138–145. 6 indexed citations
14.
Ciaffi, Laura, Sabrina Eymard‐Duvernay, Suzanne Izard, et al.. (2017). Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results. Journal of the International AIDS Society. 20. 29–29. 1 indexed citations
15.
Fokam, Joseph, Désiré Takou, Maria Mercedes Santoro, et al.. (2015). Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines. AIDS Research and Human Retroviruses. 32(4). 329–333. 5 indexed citations
16.
Cohen, Julien, Charles Kouanfack, Sylvie Boyer, et al.. (2012). Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon – Data from the STRATALL ANRS 12110/ESTHER trial. AIDS Care. 25(3). 347–355. 6 indexed citations
17.
Fokunang, Charles, et al.. (2010). Evaluation of hepatotoxicity and nephrotoxicity in HIV patients on highly active anti-retroviral therapy. Journal of AIDS and HIV Research. 2(3). 46–57. 10 indexed citations
18.
Aghokeng, Avelin F., Charles Kouanfack, Christian Laurent, et al.. (2010). Frequency of antiretroviral resistance mutations among ART-naive HIV-1-infected populations in rural areas from Cameroon. Antiviral Therapy. 15(4). 1 indexed citations
19.
Pouillot, Régis, Yacouba Njankouo Mapoure, Mathurin Cyrille Tejiokem, et al.. (2008). Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Laurent, Christian, Anke Bourgeois, Eitel Mpoudi‐Ngolé, et al.. (2008). Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon. AIDS Research and Human Retroviruses. 24(3). 393–400. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026